NETJOY(02131): Bao Xiaofeng Appointed as Independent Non-Executive Director and Member of the Audit Committee
Netjoy (02131) announced that the Board hereby warmly welcomes Mr. Bao Xiaofeng as an independent non-executive Director and a member of the audit committee of the Board, with effect from September 21, 2026.
NETJOY (02131) announced that the Board would like to warmly welcome Mr. Bao Xiaofeng on his appointment as an independent non-executive Director and a member of the audit committee of the Board, with effect from September 21, 2026.
In order to optimize the composition of the Board and further improve the Company's corporate governance structure, Mr. Xu Jiaqing has been re-designated from an executive Director to a non-executive Director, with effect from September 21, 2026. Mr. Xu will continue to serve as the chairman of the Board, the chairman of the nomination committee and the authorized representative of the Company, but he will resign as the vice president and chief marketing officer of the Company, with effect from September 21, 2026.
Mr. Dai Liqun, an executive Director, has been appointed as the chief executive officer of the Company, with effect from September 21, 2026. Mr. Dai will continue to serve as an executive Director.
Related Articles

CF PHARMTECH (02652): ICF004 Completes Dosing of First Healthy Volunteer in Phase I Clinical Trial

US Stock Market Move | Paramount Skydance may clear acquisition hurdles; Warner Bros. Discovery (WBD.US) rises over 10%.

Meta (META.US) 2026 Developer Conference Takes the Stage This Week: Smart Glasses and Phoenix Poised for Launch, Muse AI Is the Biggest Highlight; Wells Fargo & Company Raises Price Target to $796
CF PHARMTECH (02652): ICF004 Completes Dosing of First Healthy Volunteer in Phase I Clinical Trial

US Stock Market Move | Paramount Skydance may clear acquisition hurdles; Warner Bros. Discovery (WBD.US) rises over 10%.

Meta (META.US) 2026 Developer Conference Takes the Stage This Week: Smart Glasses and Phoenix Poised for Launch, Muse AI Is the Biggest Highlight; Wells Fargo & Company Raises Price Target to $796

RECOMMEND





